Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Glucagon polyclonal antibody

 
BML-GA1181-0025 25 µl 108.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Host:Rabbit
 
Immunogen:Natural pig pancreatic glucagons.
 
UniProt ID:P01274
 
Species reactivity:Mammalian
 
Applications:IHC
 
Recommended Dilutions/Conditions:Immunohistochemistry (1:200-1:8,000) depending on processing. See application notes.
Optimal conditions must be determined individually for each application.
 
Application Notes:Test tissues: Mammalian endocrine pancreas (A cells) and colon (EG cells) are heavily labelled with this antiserum.

Fixatives: All standard cross-linking agents may be used.

Processing: Paraffin wax- and resin-embedded tissue has been used successfully.

Dilution range: 1:1,000-1:8,000, using overnight incubation and indirect immunoperoxidase procedure (such as PAP7 or ABC-peroxidase). 1:200-1:1,200, using overnight incubation and indirect immunofluorescence procedures.

Specificity: Immunostaining may be abolished by pre-incubation with 10nmol synthetic or natural glucagon per mL diluted antibody. Glucagon-like peptides 1 and 2 at the same concentration have no effect on immunostaining.
 
Formulation:Liquid. Neat serum.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Scientific Background:The existence of a pancreas-derived hyperglycaemic factor has been known for over 70 years, but it was not until 1983 that the primary structure of the human glucagon precursor molecule was described. The human prepro-glucagon gene encodes a 180 amino acid, 21kDa protein which includes one copy each of the biologically active molecules glucagon and glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).

Pro-glucagon is cleaved in the pancreatic A-cells to release glucagon and the other pro-glucagon-derived peptides, but in enteroglucagon (EG)-containing L-cells of mammalian gut the enzymatic conversion of ‘glicentin’ to ‘pancreatic’ glucagon does not occur. Recent work has shown that prohormone convertase-1 (PC1) is capable of processing pro-glucagon to produce the intestinal peptides, glicentin, oxyntomodulin and GLPs, whereas PC2 processes pro-glucagon to glicentin but does not produce glucagon either alone or in combination with other enzymes or with other known molecular chaperones.
 
BML-GA1181 schematic
Schematic representation of the human prepro-glucagon protein.
Please mouse over
BML-GA1181 schematic

Product Literature References

Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia: L.R. Vieira, et al.; J. Bras. Pneumol. 41, 167 (2015), Application(s): Immunohistochemistry using mouse pancreatic tissue sections, Abstract; Full Text

Related Products

Glucagon (1-29) (human, rat, porcine) 

16941-32-5, ≥97% | Print as PDF
 
BML-GP1432-0100 100 µg 233.00 USD
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Glucagon
By biological activity:
Glucagon Polyclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Catalogs
Diabetes Catalog
Diabetes Catalog
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,